Technical Analysis for ABSI - Absci Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 2.68 | -1.47% | -0.04 |
ABSI closed down 1.47 percent on Wednesday, November 20, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Possible NR7 | about 17 hours ago |
| Possible Inside Day | about 17 hours ago |
| 1.5x Volume Pace | about 21 hours ago |
| Down 5% | about 22 hours ago |
| Down 3% | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Artificial Intelligence Pharmacy Drug Discovery Synthetic Biology Genscript Biotech
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Artificial Intelligence Pharmacy Drug Discovery Synthetic Biology Genscript Biotech
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.72 |
| 52 Week Low | 1.35 |
| Average Volume | 1,012,635 |
| 200-Day Moving Average | 4.33 |
| 50-Day Moving Average | 3.86 |
| 20-Day Moving Average | 3.70 |
| 10-Day Moving Average | 3.32 |
| Average True Range | 0.28 |
| RSI (14) | 25.93 |
| ADX | 22.46 |
| +DI | 14.74 |
| -DI | 40.70 |
| Chandelier Exit (Long, 3 ATRs) | 3.62 |
| Chandelier Exit (Short, 3 ATRs) | 3.29 |
| Upper Bollinger Bands | 4.84 |
| Lower Bollinger Band | 2.55 |
| Percent B (%b) | 0.06 |
| BandWidth | 61.77 |
| MACD Line | -0.33 |
| MACD Signal Line | -0.18 |
| MACD Histogram | -0.1504 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.94 | ||||
| Resistance 3 (R3) | 2.92 | 2.82 | 2.89 | ||
| Resistance 2 (R2) | 2.82 | 2.76 | 2.83 | 2.88 | |
| Resistance 1 (R1) | 2.75 | 2.71 | 2.70 | 2.77 | 2.86 |
| Pivot Point | 2.65 | 2.65 | 2.63 | 2.66 | 2.65 |
| Support 1 (S1) | 2.58 | 2.59 | 2.53 | 2.60 | 2.50 |
| Support 2 (S2) | 2.48 | 2.54 | 2.49 | 2.48 | |
| Support 3 (S3) | 2.41 | 2.48 | 2.47 | ||
| Support 4 (S4) | 2.43 |
